Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |